# A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia

Study · id `cardio:ct-nct06173570` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06173570](<https://clinicaltrials.gov/study/NCT06173570>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06173570

Browse, organ or system: Metabolism  
Browse, condition area: Risk and prevention; Diabetes and metabolic disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 428 participants.

## Technical summary

Registry record NCT06173570. Randomized; quadruple masking; primary purpose treatment. Start 2024-01-19 (actual); primary completion 2024-09-30 (actual). Results posted on 2025-11-17.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 428 participants (enrolled count; ClinicalTrials.gov record NCT06173570, source copy `cardio:ctgov-nct06173570-2025-11-17`, retrieved 2026-10-31)
- Started: 2024-01-19 (actual) (ClinicalTrials.gov record NCT06173570, source copy `cardio:ctgov-nct06173570-2025-11-17`, retrieved 2026-10-31)
- Primary completion: 2024-09-30 (actual) (ClinicalTrials.gov record NCT06173570, source copy `cardio:ctgov-nct06173570-2025-11-17`, retrieved 2026-10-31)
- Completion: 2024-09-30 (actual) (ClinicalTrials.gov record NCT06173570, source copy `cardio:ctgov-nct06173570-2025-11-17`, retrieved 2026-10-31)
- Results first posted: 2025-11-17 (ClinicalTrials.gov record NCT06173570, source copy `cardio:ctgov-nct06173570-2025-11-17`, retrieved 2026-10-31)
- Countries: United States; Canada; Czechia; Denmark; Hungary; Japan; Slovakia; Spain (ClinicalTrials.gov record NCT06173570, source copy `cardio:ctgov-nct06173570-2025-11-17`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06173570-2025-11-17`, retrieved 2026-10-31)

## The registry's words

- Brief title: A Study to Assess the Efficacy, Safety and Tolerability of Different Doses of AZD0780 in Patients With Dyslipidemia
- Acronym: PURSUIT
- Condition: Dyslipidemia
- Intervention (Drug): AZD0780
- Intervention (Drug): Placebo
- Lead sponsor: AstraZeneca
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Dyslipidemia (`cardio:dyslipidemia`)
- Registry lists this organization as the lead sponsor: AstraZeneca (`cardio:astrazeneca`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: An Oral PCSK9 Inhibitor for Treatment of Hypercholesterolemia: The PURSUIT Randomized Trial (`cardio:pubmed-40167413`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 34a62c759bc22686565fad3bb0cfd942c1a290c5d08a2d68cc121e72b5e3a35f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
